As of 2025-06-04, the Fair Value of Recce Pharmaceuticals Ltd (RCE.AX) is -0.34 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.33 AUD, the upside of Recce Pharmaceuticals Ltd is -205.31%.
With the market price of 0.33 AUD and our fair value calculation, Recce Pharmaceuticals Ltd (RCE.AX) is not a good investment. Investing in RCE.AX stocks now will result in a potential loss of 205.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -4.32 | -13.51 | -10.99 | -13.08 | -17.66 | -11.91 |
| YoY growth | -54.77% | -213.05% | 18.70% | -19.03% | -35.06% | -60.64% |
| Market Cap (mil) | 85.15 |
| P/E | |
| Forward P/E |
| EPS | -0.07 |
| Avg earnings growth rate | -60.64% |
| TTM earnings | -17.94 |